Iswarya fertility chain raises ₹350 crore from OrbiMed after 40 years of self-funding

Short summary

Iswarya, an Indian fertility treatment chain, raised ₹350 crore from OrbiMed after 40 years of operating without external funding. The capital will be used to expand fertility treatment access across underserved regions of India. This marks a rare instance of a healthcare business bootstrapping for four decades before taking institutional capital.

• •Iswarya raised ₹350 crore from OrbiMed after 40 self-funded years
• •Funds will expand fertility treatment across underserved India
• •Rare example of a four-decade bootstrapped healthcare chain taking institutional capital

Generated with AI, which can make mistakes.